首页> 外文期刊>The pharmaceutical journal >One year on:what has been the impact of the clinical trials directive?
【24h】

One year on:what has been the impact of the clinical trials directive?

机译:一年:临床试验指令产生了什么影响?

获取原文
获取原文并翻译 | 示例
           

摘要

After a background paper on the development and the requirements of the clinical trials directive (CTD) by Brian Davis of the Medicines and Healthcare products Regulatory Agency,the feedback from the regulators was presented.Bronwyn Phillips,an MHRA inspector,explained that from 1 May 2004 the voluntary programme of inspection had ceased.Around 175 applications have since been received,the majority (120) from existing licensed sites.
机译:在药品和保健产品监管局的Brian Davis撰写了有关临床试验指令(CTD)的发展和要求的背景文件后,提出了监管者的反馈意见。MHRA检查员布朗温·菲利普斯(Bronwyn Phillips)解释说,从5月1日开始2004年,自愿检查计划已经停止。自那时以来,已收到大约175份申请,其中大部分(120)来自现有的许可站点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号